In this study, we aim to elucidate the impact and mechanism of miR-144-3p in modulating the Wnt/β-catenin signaling pathway by targeting SFRP1, thereby offering novel biomarkers for the diagnosis, prognosis, and molecular targeted therapy of colon carcinoma. Here, SFRP1 is linked to colon carcinoma.